164 related articles for article (PubMed ID: 11758957)
21. Risk of bacteremia in young children with pneumonia treated as outpatients.
Shah SS; Alpern ER; Zwerling L; McGowan KL; Bell LM
Arch Pediatr Adolesc Med; 2003 Apr; 157(4):389-92. PubMed ID: 12695236
[TBL] [Abstract][Full Text] [Related]
22. [Thousand faces of Streptococcus pneumonia (pneumococcus) infections].
Szabó BG; Lénárt KS; Kádár B; Gombos A; Dezsényi B; Szanka J; Bobek I; Prinz G
Orv Hetil; 2015 Nov; 156(44):1769-77. PubMed ID: 26498896
[TBL] [Abstract][Full Text] [Related]
23. Pneumococcal bacteremia in febrile infants presenting to the emergency department 8 years after the introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
Benito-Fernández J; Mintegi S; Pocheville-Gurutzeta I; Sánchez Etxaniz J; Gómez Cortés B; Hernández Almaraz JL
Pediatr Infect Dis J; 2010 Dec; 29(12):1142-4. PubMed ID: 20592642
[TBL] [Abstract][Full Text] [Related]
24. Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.
Flamaing J; Verhaegen J; Vandeven J; Verbiest N; Peetermans WE
J Antimicrob Chemother; 2008 Jan; 61(1):143-9. PubMed ID: 17999974
[TBL] [Abstract][Full Text] [Related]
25. Pneumococcal conjugate vaccine for young children.
Selman S; Hayes D; Perin LA; Hayes WS
Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
[TBL] [Abstract][Full Text] [Related]
26. Recurrence of occult pneumococcal bacteremia by an identical strain in an apparently healthy child.
Matsubara K; Fukaya T; Ubukata K; Chen M; Nigami H; Harigaya H; Nozaki H; Tanaka T
J Infect; 2007 Feb; 54(2):e87-90. PubMed ID: 16762416
[TBL] [Abstract][Full Text] [Related]
27. Predictors for bacteremia in febrile sickle cell disease children in the post-7-valent pneumococcal conjugate vaccine era.
Chang TP; Kriengsoontorkij W; Chan LS; Wang VJ
J Pediatr Hematol Oncol; 2013 Jul; 35(5):377-82. PubMed ID: 23588338
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
Shibl AM; Memish ZA; Al-Kattan KM
Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
[TBL] [Abstract][Full Text] [Related]
29. Occult bacteremia in young febrile children.
Kuppermann N
Pediatr Clin North Am; 1999 Dec; 46(6):1073-109. PubMed ID: 10629675
[TBL] [Abstract][Full Text] [Related]
30. Emergency department epidemiology of pneumococcal bacteremia in children since the institution of widespread PCV7 vaccination.
Mistry RD; Wedin T; Balamuth F; McGowan KL; Ellison AM; Nelson KA; McLoughlin RJ; Alpern ER
J Emerg Med; 2013 Dec; 45(6):813-20. PubMed ID: 23992851
[TBL] [Abstract][Full Text] [Related]
31. Invasive bacterial infections in a paediatric emergency department in the era of the heptavalent pneumococcal conjugate vaccine.
Herrero M; Alcalde M; Gómez B; Hernández JL; Sota M; Benito J; Mintegi S
Eur J Emerg Med; 2012 Apr; 19(2):89-94. PubMed ID: 21659882
[TBL] [Abstract][Full Text] [Related]
32. Bacteremia in children with sickle hemoglobinopathies.
Narang S; Fernandez ID; Chin N; Lerner N; Weinberg GA
J Pediatr Hematol Oncol; 2012 Jan; 34(1):13-6. PubMed ID: 22215095
[TBL] [Abstract][Full Text] [Related]
33. Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program.
Watson M; Roche P; Bayley K; Bell JM; Collignon P; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Smith HV; Brown M; Stylianopoulos J; Turnidge J
Commun Dis Intell Q Rep; 2004; 28(4):455-64. PubMed ID: 15745392
[TBL] [Abstract][Full Text] [Related]
34. [Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].
Albrecht P; Antczak A; Hryniewicz W; Skoczyńska A; Radzikowski A; Kedziora-Kornatowska K; Bernatowska E; Stompór T; Grodzicki T; Gyrczuk E; Imiela J; Jedrzejczak W; Windak A
Pol Merkur Lekarski; 2014 Feb; 36(212):79-87. PubMed ID: 24720101
[TBL] [Abstract][Full Text] [Related]
35. Fever without localizing signs in children: a review in the post-Hib and postpneumococcal era.
Chancey RJ; Jhaveri R
Minerva Pediatr; 2009 Oct; 61(5):489-501. PubMed ID: 19794375
[TBL] [Abstract][Full Text] [Related]
36. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
Lynch JP; Zhanel GG
Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
[TBL] [Abstract][Full Text] [Related]
37. Streptococcus pneumoniae bacteraemia in children.
Myers C; Gervaix A
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S24-8. PubMed ID: 17707612
[TBL] [Abstract][Full Text] [Related]
38. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era.
Lee GM; Harper MB
Arch Pediatr Adolesc Med; 1998 Jul; 152(7):624-8. PubMed ID: 9667531
[TBL] [Abstract][Full Text] [Related]
39. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
[TBL] [Abstract][Full Text] [Related]
40. Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population.
Ellison AM; Ota KV; McGowan KL; Smith-Whitley K
Pediatr Infect Dis J; 2012 May; 31(5):534-6. PubMed ID: 22228232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
